Natco Pharma Soars After Generic Ozempic Approval | Big GLP-1 Opportunity? | Business News | ET Now
Автор: ET Now
Загружено: 2026-02-16
Просмотров: 217
Описание:
Natco Pharma shares rallied after the company received approval from India’s drug regulator, CDSCO, for its generic version of semaglutide — the key ingredient in Ozempic. With demand for GLP-1 drugs soaring globally due to rising diabetes and obesity cases, this approval could open up a massive growth opportunity for Natco.
Will this mark the beginning of a strong revenue cycle for the pharma major? How big is the semaglutide opportunity in India and globally? Watch for full analysis on the stock’s prospects, competition, and sector impact.
#natcopharma #semaglutide #ozempic #pharmastocks #stockmarketindia #glp1 #diabetescare #obesitytreatment #indianstockmarket #cdsco #pharmanews #sharemarket #investing
control your money with economic times now.
#etnow #businessnews #budget2026withetnow
YouTube Channel - / @etnow
Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow
Subscribe Now To Our Network Channels :-
ET Now Swadesh: / etnowswadesh
Times Now: http://goo.gl/U9ibPb
Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
Website - https://www.etnownews.com
Follow us on Google News for latest updates
ET Now: https://news.google.com/publications/...
Times Now Navbharat: https://bit.ly/3zDaKJo
Times Now : https://bit.ly/3CyrrYg
Zoom: https://bit.ly/3CEK0dv
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
